Temporal Changes in Reporting of Neurodevelopmental Outcomes After Maternal Exposure to Valproate: A Contribution of the ConcePTION Project
Drug Safety · 2025
DOI: 10.1007/s40264-025-01583-0 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Drug Safety, 2025. Verfasst von Dimitra Gkolfi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Valproic Acid, Prenatal Exposure Delayed Effects, Anticonvulsants, Neurodevelopmental Disorders. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Innovative Medicines Initiative.
Abstract (Originalsprache)
BACKGROUND: Understanding changes over time in the quantity and characteristics of reports submitted to pharmacovigilance centres is crucial for accurately interpreting safety signals associated with exposure during pregnancy. OBJECTIVE: We aimed to assess temporal changes in the outcome measures for signal detection, specifically the number and clustering of reported adverse events concerning maternal valproate exposure and neurodevelopmental outcomes in offspring. METHODS: An observational study using VigiBase analysed changes in the number of reports and event clustering related to neurodevelopmental outcomes in offspring following valproate exposure during pregnancy. Reports from the start of VigiBase till 3 April, 2023 were identified using the VigiBase pregnancy algorithm. Time trend graphs illustrated reporting behavioural changes, with particular focus on the impact of major scientific publications and regulatory decisions. Report clusters, identified by the vigiGroup method, were randomised and independently reviewed by three qualified reviewers for clinical relevance to neurodevelopmental outcomes, morphological disorders or other entities. RESULTS: Over time, an increase in reports mentioning neurodevelopmental outcomes and a more diverse pattern of adverse events for valproate has been reported. An increase in the number of reports following key publications and international regulatory guidelines was visible. CONCLUSIONS: Our study revealed an increase over time in reporting and awareness of neurodevelopmental outcomes and valproate exposure during pregnancy, following important publications and regulatory decisions. However, the extent to which these developments contributed to the observed increase remains unclear.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, University of Groningen, Groningen, The Netherlands.
- Uppsala Monitoring Centre, Uppsala, Sweden.
- Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands.
- Division of Neuroscience, University of Manchester, Manchester, UK.
- Royal Manchester Children's Hospital, Manchester, UK.
- University of Kwazulu-Natal, KRISP, Durban, South Africa.
Förderung
- Innovative Medicines Initiative
Zitieren
APA
Gkolfi, D., van Rijt-Weetink, Y. R. J., Taavola-Gustafsson, H., Sandberg, L., Raemaekers, B. C., van Hunsel, F. P. A. M., Passier, A. L. M., Bromley, R. L., Yates, L. M., & van Puijenbroek, E. P. (2025). Temporal Changes in Reporting of Neurodevelopmental Outcomes After Maternal Exposure to Valproate: A Contribution of the ConcePTION Project. Drug Safety. https://doi.org/10.1007/s40264-025-01583-0
Vancouver
Gkolfi D, van Rijt-Weetink YRJ, Taavola-Gustafsson H, Sandberg L, Raemaekers BC, van Hunsel FPAM, et al. Temporal Changes in Reporting of Neurodevelopmental Outcomes After Maternal Exposure to Valproate: A Contribution of the ConcePTION Project. Drug Safety. 2025. doi:10.1007/s40264-025-01583-0
BibTeX
@article{Gkolfi2025,
author = {Gkolfi, Dimitra and van Rijt-Weetink, Yrea R J and Taavola-Gustafsson, Henric and Sandberg, Lovisa and Raemaekers, Boukje C and van Hunsel, Florence P A M and Passier, Anneke L M and Bromley, Rebecca L and Yates, Laura M and van Puijenbroek, Eugène P},
title = {Temporal Changes in Reporting of Neurodevelopmental Outcomes After Maternal Exposure to Valproate: A Contribution of the ConcePTION Project},
journal = {Drug Safety},
year = {2025},
doi = {10.1007/s40264-025-01583-0}
}
EUVIMED